Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Mitsubishi Tanabe Pharma Corp    4508   JP3469000008

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Manufactures and distributes pharmaceuticals, pet products and medicines

Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products.

Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera.

The company operates through Pharmaceuticals segment.

Mitsubishi Tanabe Pharma was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan.

Number of employees : 7 280 persons.
Sales per Businesses
20162017Delta
JPY (in Million)%JPY (in Million)%
Pharmaceutical Business431,701100%423,977100% -1.79%
Sales per Regions
20162017Delta
JPY (in Million)%JPY (in Million)%
Japan314,76472.9%320,36975.6% +1.78%
Europe66,96215.5%57,42513.5% -14.24%
North America31,0437.2%27,0396.4% -12.9%
Asia18,5074.3%18,7524.4% +1.32%
Other425.000.1%392.000.1% -7.76%
Managers
NameAgeSinceTitle
Masayuki Mitsuka, PhD632007President, CEO & Representative Director
Eizou Tabaru592014Director, General Manager-Finance & Accounting
Yoshiaki Ishizaki622007Director & Managing Executive Officer
Seiichi Murakami601980Director & Head-External Affairs
Takashi Kobayashi621980Representative Director
Shigehiko Hattori762011Outside Director
Takashi Tanaka61-Director
Shigeki Iwane642016Outside Director
Tsutomu Kamijo63-Outside Director
Tsutomu Anno--Executive Officer & Deputy General Manager-Sales
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 0.001 561,417,916 237,749,488 42.3% 430,012 0.1% 42.3%
Shareholders
NameEquities%
Mitsubishi Chemical Holdings Corp. 316,320,000 56.3%
Nippon Life Insurance Co. 12,065,000 2.15%
Mitsubishi UFJ Financial Group, Inc. 9,372,113 1.67%
BlackRock Fund Advisors 5,933,200 1.06%
The Vanguard Group, Inc. 5,565,960 0.99%
Norges Bank Investment Management 4,460,317 0.79%
Nomura Asset Management Co., Ltd. 4,065,700 0.72%
Nipro Corp. 3,821,700 0.68%
APG Asset Management NV 3,272,685 0.58%
Mellon Capital Management Corp. 1,768,877 0.32%
Holdings
NameEquities%Valuation
SUZUKEN CO., LTD. (9987) 1,548,1911.50%55,014,998 USD
Alfresa Holdings Corporation (2784) 2,225,8120.95%40,713,774 USD
Medipal Holdings Corp (7459) 2,125,7320.87%36,900,284 USD
VITAL KSK HOLDINGS INC (3151) 1,455,2962.38%12,062,279 USD
Mitsubishi Tanabe Pharma Corp (4508) 429,7000.077%9,848,763 USD
T&D Holdings Inc (8795) 572,5000.087%8,307,902 USD
HOKUYAKU TAKEYAMA Holdings,Inc. (3055) 1,176,3424.71%7,043,524 USD
KOEI CHEMICAL COMPANY, LIMITED (4367) 182,0003.71%5,392,174 USD
TSURUHA HOLDINGS INC. (3391) 40,0000.082%4,779,461 USD
Create SD Holdings Co Ltd (3148) 3,6000.0054%95,209 USD
Company contact information
Mitsubishi Tanabe Pharma Corp.
3-2-10 Dosho-machi
Chuo-Ku
Osaka 541-8505

Phone : +81.6.6205.5085
Fax : +81.6.6205.5262
Web : www.mt-pharma.co.jp
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
MITSUBISHI TANABE PHARMA CORP13.26%12 802
JOHNSON & JOHNSON22.11%377 585
NOVARTIS13.50%226 453
ROCHE HOLDING LTD.5.55%215 760
PFIZER10.31%213 372
MERCK AND COMPANY7.88%173 214
AMGEN27.41%135 924
SANOFI9.90%125 891
BAYER19.94%115 989
CELGENE CORPORATION18.51%107 315
BRISTOL-MYERS SQUIBB COMPANY9.00%104 463
GLAXOSMITHKLINE-1.82%99 651
NOVO NORDISK A/S22.22%98 848
ABBOTT LABORATORIES45.20%96 897
ELI LILLY AND COMPANY16.56%94 388
ASTRAZENECA16.64%86 419
ALLERGAN PLC-10.89%62 565
SHIRE-20.59%44 568
TAKEDA PHARMACEUTICAL CO LTD31.02%44 097
ASTELLAS PHARMA INC-6.98%27 649
JIANGSU HENGRUI MEDICINE CO LTD40.24%27 044
© 2017 People , Fundamentals and Ownership